Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 95 clinical trials
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A (HEM-POWR)

The aim of the HEM-POWR study is to understand better how Damoctocog alfa pegol (Jivi) is used to treat people with Hemophilia A in day-to-day life, how well the treatment is tolerated and how

jivi
damoctocog alfa pegol
antihemophilic factor
  • 97 views
  • 03 May, 2022
  • 22 locations
A Post Marketing Surveillance Study for ADYNOVATE in South Korea

The purpose of this study is to characterize the safety and describe hemostatic effectiveness in patients receiving ADYNOVATE in routine clinical practice.

hemostatic
adynovate
  • 3 views
  • 03 Feb, 2022
  • 8 locations
Evaluation of Long-term Safety of ADYNOVI/ADYNOVATE (Antihaemophilic Factor [Recombinant] PEGylated Rurioctocog Alfa Pegol) in Patients With Haemophilia A - An ADYNOVI/ADYNOVATE Post-Authorisation Safety Study (PASS)

The main purpose is to evaluate the long-term safety of ADYNOVI/ADYNOVATE prophylaxis in patients with haemophilia A when used under standard clinical practice in the real-world setting.

antihemophilic factor
adynovate
  • 4 views
  • 09 Sep, 2021
  • 20 locations
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding (HA-SAFE)

Factor VIII (FVIII) medication for the treatment of hemophilia A (bleeding disorder resulting from a lack of FVIII). It is manufactured via recombinant technology and has an extended half-live, i.e. it

  • 0 views
  • 02 May, 2022
  • 4 locations
The European Paediatric Network for Haemophilia Management ( PedNet Registry)

Rationale Haemophilia is a rare disease; to improve knowledge international collaboration is needed. Well-defined clinical data will be collected from complete

hemophilia
antihemophilic factor
  • 38 views
  • 26 Jan, 2021
  • 37 locations
World Bleeding Disorders Registry

The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to

bleeding tendency
hemophilia
  • 0 views
  • 25 Jan, 2021
  • 1 location
Patient Reported Outcomes Burdens and Experiences - Phase 3 (PROBE-3)

The PROBE Phase-3 study will collect data on patient reported outcomes, burdens, and experiences in patients living with hemophilia. The investigators will perform comparisons among countries

  • 76 views
  • 04 Mar, 2022
  • 1 location
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and acquired hematologic conditions, not just those for bleeding and clotting disorders, is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have …

bleeding tendency
coagulation studies
haemostasis
clot
thrombosis
  • 0 views
  • 17 Dec, 2021
  • 1 location
National Longitudinal Cohort of Hematological Diseases (NICHE)

, hemophilia, aplastic anemia, leukemia, myelodysplastic syndrome, lymphoma, bleeding disorders or received bone marrow transplantation in the investigating hospitals from January 1, 2020, and collect basic

anemia
leukemia
bone marrow procedure
multiple myeloma
lymphoma
  • 0 views
  • 24 Mar, 2022
  • 1 location
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

SARS
Accepts healthy volunteers
  • 2711 views
  • 04 Mar, 2022
  • 43 locations